WEBER leaves the Vivactis Group in line with the short-term strategy and reorganization process the Belgian holding company is implementing.
Madrid, the 3rd of July 2024 – At the end of June 2024, the VIVACTIS Group has decided to sell its entire stake in WEBER to Álvaro Hidalgo, one of its founders, as part of its reorganization plan and its short- and long-term strategy.
In this new phase, the parties have agreed to maintain close and fruitful collaborative relationships, maximizing their potential synergies, based on mutual knowledge and their complementary portfolios. In this way, the two entities will be able to independently offer to their clients and the market cross-cutting, innovative and exclusive skills.
This new form of collaboration will allow each party to regain greater agility and responsiveness in serving its market.
Contact
Marta Romero
Tel: +34 91 639 38 24
Email: comunicacion@weber.org.es
About Vivactis Group
Vivactis is an independent European healthcare consultancy group involved in several key areas for the healthcare industry such as clinical research, marketing and communication, market access, health economics and public affairs (company website: https://vivactis.com/).
About Weber
Weber is a consulting company specializing in health technology assessment, health economics and market access. Part of its activity is focused on research work, with the clear objective of contributing to the development of decision-making tools. Our multidisciplinary team allows the company to reach out strategic projects that provide comprehensive value (company website: https://weber.org.es/).
In 2017, WEBER set up the Weber Foundation to promote knowledge dissemination projects that contribute to the sustainability of the National Health System.